In 2019, The Economist held its inaugural Antimicrobial resistance summit. Bringing together policymakers, pharmaceutical companies, academic researchers and NGOs, the event made a compelling case for increasing both financial investment and policy attention to AMR to avoid a future public health crisis.
This year the goal is to expand the community of discussants, to include a greater focus on environment, food and agriculture, which are underappreciated domains of AMR. The potential of AI and machine learning for improving surveillance, and ways to develop economic impact data that can galvanise policy makers, will also be explored. The conference will provide an opportunity to evaluate progress since 2019, such as new government AMR action plans and the experiences to date of ‘push’ and ‘pull’ mechanisms to incite R&D. In the food and environment domain, the summit will look at concrete ways to reduce antibiotics in crops and livestock and explore the emergence of antimicrobial resistance genes in the food system.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.